| [1] |
Ferlay J, Soerjomatarm I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 [J]. Int J Cancer, 2015, 136(5): E359-86.
|
| [2] |
Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevealence estimates, 2000 [J]. Perspect Sex Reprod Health, 2004, 36(1): 6-10.
|
| [3] |
赵超，魏丽惠. HPV疫苗的临床应用价值 [J]. 国际生殖健康/计划生育杂志, 2015, 34(6): 462-466.
|
| [4] |
宋敬东，王健伟，韩金祥, 等. 人乳头瘤病毒疫苗的研究进展. 中国生物工程杂志, 2007, 27(4): 104-109.
|
| [5] |
Cates W Jr. Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American social health association panel [J]. Sex Transm Dis, 1999, 26(4 Suppl): S2-7.
|
| [6] |
Revzina NV, Diclemente RJ. Prevalence and incidence of human papillomavirus infection in women in the USA: a systematic review [J]. Int J STD AIDS, 2005, 16(8): 528-537.
|
| [7] |
Hariri S, Unger ER, Sternberg M, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006 [J]. J Infect Dis, 2011, 204(4): 566-573.
|
| [8] |
Kirby T. FDA approves new upgarded Gardasil 9 [J]. Lancet Oncol, 2014, 16(2): e56.
|
| [9] |
Paavonen J, Naud P, Salmeron J, et al. Efficacy of human papillomavirus(HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types(PATRICIA): final analysis of a double-blind, randomised study in young women [J]. Lancet, 2009, 374(9686): 301-314.
|
| [10] |
Munoz N, Manalastas R Jr, Pitisuttithum P, et al. Safety, immunogenicity, and efficacy of quadrivalent human papilloma-virus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial [J]. Lancet, 2009, 373(9679): 1949-1957.
|
| [11] |
Marlow LA, Zimet GD, McCaffery KJ, et al. Knowledge of human papillomavirus(HPV) and HPV vaccination: an international comparison [J]. Vaccine, 2013, 31(5): 763-769.
|
| [12] |
Marek E, Dergez T, Rebek-Nagy G, et al. Effect of an educational intervention on Hungarian adolescents′ awareness, beliefs and attitudes on the prevention of cervical cancer [J]. Vaccine, 2012, 30(48): 6824-6832.
|
| [13] |
Bowyer HL, Marlow LA, Hibbitts S, et al. Knowledge and awareness of HPV and the HPV vaccine among young women in the first routinely vaccinated cohort in England [J]. Vaccine, 2013, 31(7): 1051-1056.
|
| [14] |
World Health Organization. Human papillomavirus vaccines: WHO position paper, October 2014 [J].Wkly Epidemiol Rec, 2014, 89(43): 465-491.
|
| [15] |
Patel PR, Berenson AB. Sources of HPV vaccine hesitancy in parents [J]. Hum Vaccin Immunother,2013, 9(12): 2649-53.
|
| [16] |
Centers for Disease Control and Prevention. Human papillomavirus vaccination coverage among adolescent girls, 2007-2012, and postlicensure vaccine safety monitoring, 2006-2013-United States [J]. Weekly, 2013, 62(29): 591-595.
|
| [17] |
Licht AS, Murphy JM, Hyland AJ, et al. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception? [J]. Sex Transm Infect, 2010, 86(1): 74-78.
|
| [18] |
Lindley LL, Elkind JS, Landi SN, et al. Receipt of the Human Papillomavirus Vaccine Among Female College Students in the United States, 2009 [J]. J Am Coll Health, 2013, 61(1): 18-27.
|
| [19] |
Bernat DH, Gerend MA, Chevallier K, et al. Characteristics Associated With Initiation of the Human Papillomavirus Vaccine Among a National Sample of Male and Female Young Adults [J]. J Adolesc Health, 2013, 53(5): 630-636.
|
| [20] |
Williams WW, Lu PJ, Saraiya M, et al. Factors associated with human papillomavirus vaccination among young adult women in the United States [J]. Vaccine, 2013, 31(28): 2937-2946.
|
| [21] |
Chou B, Krill LS, Horton BB, et al. Disparities in human papillomavirus vaccine completion among vaccine initiators [J]. Obstet Gynecol, 2011, 118(1): 14-20.
|
| [22] |
Tan W, Viera AJ, Rowe-West B, et al. The HPV vaccine: Are dosing recommendations being followed? [J]. Vaccine, 2011, 29(14): 2548-2554.
|
| [23] |
Rondy M, van Lier A, van de Kassteele J, et al. Determinants for HPV vaccine uptake in the Netherlands: a multilevel study [J]. Vaccine, 2010, 28(9): 2070-2075.
|
| [24] |
Dorleans F, Giambi C, Dematte L, et al. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey [J]. Euro Surveill, 2010, 15(47): 19730.
|
| [25] |
Lenselink CH, Gerrits MM, Melchers WJ, et al. Parental acceptance of human papillomavirus vaccines [J]. Eur J Obstet Gynecol Reprod Biol, 2008, 137(1): 103-107.
|
| [26] |
Zhang SK, Pan XF, Wang SM, et al. Perceptions and acceptability of HPV vaccination among parents of young adolescents: A multicenter national survey in China [J]. Vaccine, 2013, 31(32): 3244-3249.
|
| [27] |
Akanbi OA, Lyanda A, Osundare F, et al. Perceptions of Nigerian women about human papilloma virus, cervical cancer, and HPV vaccine [J]. Scientifica(Cario), 2015, 2015: 285702.
|
| [28] |
Brinth L, Theibel AC, Pors K, et al. Suspected side effects to the quadrivalent human papilloma vaccine [J]. Dan Med J, 2015, 62(4): A5064.
|
| [29] |
赵超，魏丽惠. HPV疫苗的安全性问题 [J]. 实用妇产科杂志, 2010, 26(3): 174-177.
|
| [30] |
Global Advisory Committee on Vaccine Safety, 2-3 December2015 [N]. Wkly Epid Rec, 2016, 91(3): 21-31.
|
| [31] |
Aqosti JM, Goldie SJ. Introducing HPV vaccine in developing countries-key challenges and issues [J]. N Engl J Med, 2007, 356(19): 1908-1910.
|
| [32] |
GAVI injects new life into HPV vaccine rollout [R]. Lancet, 2013, 381(9879): 1688.
|
| [33] |
杨瑾，许璐洁，徐蕾,等. 西安非医学专业女大学生对HPV和HPV疫苗的认知 [J]. 中国妇幼保健研究, 2016, 27(8): 923-925.
|
| [34] |
李静，屠铮，赵超,等. 北京市社区妇女人乳头瘤病毒感染率及其对HPV和疫苗认知情况的调查分析 [J]. 中国肿瘤, 2008, 17(3): 168-172.
|
| [35] |
Franceschi S, Plummer M, Clifford G, et al. Differences in the risk of cervical cancer and human papillomavirus infection by education level [J]. Br J Cancer, 2009, 101(5): 865-870.
|
| [36] |
Zhao FH, Lin MJ, Chen F, et al. Performance of high-risk human papillomavirus DNA testing as a primary screen for cervical cancer: a pooled analysis of individual patient data from 17 population-based studies from China [J]. Lancet Oncol, 2010, 11(12): 1160-1171.
|
| [37] |
Li J, Kang LN, Li B, et al. Effect of a group educational intervention on rural Chinese women′s knowledge and attitudes about human papillomavirus(HPV) and HPV vaccines [J]. BMC Cancer, 2015, 15: 691.
|
| [38] |
曾晓敏，任泽舫，魏雪灵, 等. 中山大学本科生对HPV及疫苗认知的调查 [J]. 现代预防医学, 2015, 42(10): 1822-1825.
|
| [39] |
Centers for Disease Control and Prevention. FDA licensure of quadrivalent human papillomavirus vaccine(HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices(ACIP)[R]. MMWR Morb Mortal Wkly Rep, 2010, 59(20): 630-632.
|
| [40] |
Brabin L, Roberts SA, Stretch R, et al. A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study [J]. Br J Cancer, 2009, 101(9): 1502-1504.
|
| [41] |
Robbins SC, Bernard D, McCaffery K, et al. ″I just signed″: Factors influencing decision-making for school-based HPV vaccination of adolescent girls [J]. Health Psychol, 2010, 29(6): 618-625.
|
| [42] |
Zimet GD, Mays RM, Sturm LA, et al. Parental attitudes about sexually transmitted infection vaccination for their adolescent children [J]. Arch Pediatr Adolesc Med, 2005, 159(2): 132-137.
|
| [43] |
唐良萏，冷若冰. 人乳头瘤病毒的临床应用 [J]. 实用妇产科杂志, 2013, 29(3): 172-174.
|
| [44] |
Etter DJ, Zinet GD, Rickert VI. Human papillomavirus vaccine in adolescent women: a 2012 update [J]. Curr Opin Obster Gynecol, 2012, 24(5): 305-310.
|
| [45] |
Reindl BM, Brown C. Religion and preventative health care utilization among the elderly [J]. Soc Sci Med, 2004, 58(1): 109-118.
|
| [46] |
Schiller PL, Levin JS. Is there a religious factor in health care utilization? A review [J]. Soc Sci Med, 1988, 27(12): 1369-1379.
|
| [47] |
Rachel C, Shelton, Anna C, et al. HPV vaccine decision-making and acceptance: does religion play a role? [J]. J Relig Health, 2013, 52(4): 1120-1130.
|
| [48] |
Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among californian parents of daughters: a representative statewide analysis [J]. J Adolesc Health, 2007, 40(2): 108-115.
|
| [49] |
Bernat DH, Harpin SB, Eisenberg ME, et al. Parental Support for the Human Papillomavirus Vaccine [J]. J Adolesc Health, 2009, 45(5): 525-527.
|
| [50] |
Patel PR, Berenson AB. The internet′s role in HPV vaccine education [J]. Hum VaccinImmunother, 2014, 10(5): 1166-1170.
|
| [51] |
Habel MA, Liddon N, Stryker JE. The HPV vaccine: a content analysis of online news stories [J]. J Womens Health, 2009, 18(3): 401-407.
|
| [52] |
Kelly BJ, Leader AE, Mittermaier DJ, et al. The HPV vaccine and the medial: how has the topic been covered and what are the effects on knowledge about the virus and cervical cancer? [J]. Patient EducCouns, 2009, 77(2): 308-313.
|
| [53] |
Hughes J, Cates JR, Liddon N, et al. Disparities in how parents are learning about the human papillomavirus vaccine [J]. Cancer Epidemiol Biomarkers Prev, 2009, 18(2): 363-372.
|
| [54] |
Boyer C, Selby M, Scherrer JR, et al. The Health On the Net Code of Conduct for medical and health Websites [J]. Comput Biol Med, 1998, 28(5): 603-610.
|